Lp(a) predictive of ‘extracoronary’ vascular disease

Key takeaways:

Lp(a) was linked to increased risk for PAD, major adverse limb events and carotid stenosis.

Lp(a) may be a therapeutic target for reducing residual risk in treatment of atherosclerotic vascular disease.

Elevated lipoprotein(a) was a significant marker of risk for atherosclerotic vascular disease beyond coronary heart disease, including peripheral artery disease and major adverse limb events, researchers reported.

Although elevated Lp(a) was prevalent among people with carotid stenosis , the link between Lp(a) and stroke was not significant, according to study findings published in Circul a tion .

Lp(a) was linked to increased risk for PAD, major adverse limb events and carotid stenosis. Image: Adobe Stock

“Despite research examining the role of Lp(a) in the de